The mission of the Division of Intramural Research (DIR) Malaria Research Program (MRP) is to seek fundamental knowledge about the interactions of malaria parasites with the human host and the mosquito vectors that transmit them and to apply this knowledge to prevent disease, enhance health, and improve the quality of life in malaria endemic areas.
The mission of the MRP is to seek fundamental knowledge about the interactions of malaria parasites with the human host and the mosquito vectors that transmit them and to apply this knowledge to prevent disease, enhance health, and improve the quality of life in malaria endemic areas.
The MRP includes the joint interests of three participating autonomous DIR laboratories: Laboratory of Malaria and Vector Research, Laboratory of Malaria Immunology and Vaccinology, and Laboratory of Immunogenetics. The chiefs of these three participating laboratories constitute the Executive Committee (EC). The MRP director, working with the EC, will be responsible for programmatic and operative activities.
MRP investigators explore the biology of malaria from the perspective of the human host, the Plasmodium parasite, and the mosquito vector and the interactions among them.
Fellowships will be awarded annually to a limited number of top applicants who aspire to improve our understanding of the biology, host-pathogen interactions, and transmission of malaria parasites.
This fundamental knowledge would be the basis to develop new malaria control strategies such as the following:
Dr. Carolina Barillas-MuryChief, Mosquito Immunity and Vector Competence Section, Laboratory of Malaria and Vector Research
Dr. Patrick DuffyChief, Laboratory of Malaria Immunology and Vaccinology
Dr. Susan PierceChief, Laboratory of Immunogenetics
Dr. Thomas WellemsChief, Laboratory of Malaria and Vector Research
Thomas WellemsMalaria Genetics Section
Sanjay DesaiApicomplexan Molecular Physiology Section
Louis MillerMalaria Cell Biology Section
Xin-Zhuan SuMalaria Functional Genomics Section
Patrick DuffyPathogenesis and Immunity Section
Michal FriedMolecular Pathogenesis and Biomarkers Section
Susan PierceLymphocyte Activation Section
Peter CromptonMalaria Infection Biology and Immunity Unit
Rick FairhurstMalaria Pathogenesis and Human Immunity Unit
Tian JinChemotaxis Signal Section
Eric LongMolecular and Cellular Immunology Section
Silvia BollandAutoimmunity and Functional Genomics Section
Carole LongMalaria Immunology Section
Carolina Barillas-MuryMosquito Immunity and Vector Competence Section
To meet the greatest challenges in malaria research, contemporary studies often rely on collaborative efforts among individual investigators with expertise in different areas. NIAID scientists who study malaria in three separate laboratories have come together to form the MRP and promote collaborative environments and facilitate next-level breakthroughs in malaria research. The goal of the MRP is to create, strengthen, and sustain interactions within the MRP and with other National Institutes of Health (NIH)-based investigators who are using diverse yet complementary approaches to tackle the global malaria problem.
The MRP Collaborative Research Fellowship will be awarded annually to a limited number of top applicants who aspire to improve our understanding of the biology, host-pathogen interactions, and transmission of malaria parasites. MRP fellows are expected to play a central role in initiating and maintaining close, balanced, and productive collaborations between two laboratories in the MRP or between the MRP and another NIH-based research program. To help successful applicants gain the knowledge base and skills necessary to launch their own scientific careers, the MRP Collaborative Research Fellowship will provide them the opportunities to do the following:
NIAID has a decades-long history of making advances in malaria research, including seminal discoveries that significantly improved our understanding of malaria pathogenesis, immunity and vaccinology, human and vector resistance to parasite infection and disease, and parasite resistance to antimalarial drugs.
MRP investigators envision that a more collaborative approach to research will drive the future development of affordable, point-of-care diagnostics for malaria and drug-resistant parasite infections; highly effective drugs that target essential parasite functions and are less vulnerable to acquired drug-resistance mechanisms; vaccines and adjunctive therapies that reduce the morbidity, mortality, and transmission of malaria; and novel strategies that block parasite development in mosquito vectors.
Applicants must have a Ph.D., M.D., or equivalent graduate degree awarded within five years of the fellowship start date.
The MRP Collaborative Research Fellowship provides stipend and health insurance for two years, while the primary supervisor and collaborator jointly fund research costs and travel expenses to attend meetings or perform field-based research. The primary supervisor may appoint and fund MRP fellows for an additional two or three years, contingent on the scientific excellence and productivity of the collaboration.
The applicant will identify a suitable primary supervisor, who is a current MRP investigator and together with the primary supervisor, the candidate will define a research project and a suitable collaborator, who is a current MRP or NIH investigator.
Applicants will submit a complete application consisting of the following:
Promising candidates will be invited to interview with MRP investigators within two months of submitting their application. Interviews will be held at the NIH Twinbrook laboratories in Rockville, Maryland.
Applications will be accepted throughout the year, and fellowships will be awarded on a rolling admissions schedule. A complete application package should be submitted no later than March 31, 2016, to be considered for the current application cycle. Awardees must begin their appointment no later than September 1, 2016.
Send your application and direct your questions to Dr. Silvia Bolland, Chair, MRP Collaborative Research Fellowship Selection Committee.
Last Updated December 07, 2015